Expression of concern
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
Paper Information
Record ID:
35178
Author(s):
Journal:
Publication Date:
March 17, 2021
Retraction Date:
January 24, 2022
(3.8 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Department of Gastroenterology, Klinikum Luneburg, University of Hamburg, Luneburg, Germany
- Department of Medicine, Division of Gastroenterology, Mater Dei Hospital, Msida, Malta cUniversity Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, and Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois CHUV, University Hospital Lausanne, Lausanne, Switzerland
- Department of Gastroenterology and Hepatology, CHU UCL Namur, Yvoir, Belgium
- Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven,Leuven, Belgium, and Department of Chronic Diseases, Metabolism and Ageing,TARGID-IBD, KU Leuven, Leuven, Belgium
- Infectious Diseases Service, Centro Hospitalar Universitario Sao Joao, Porto, Portugal, and Instituto de Inovacao e Investigacao em Saude [I3s], Faculty of Medicine, Department of Medicine, University of Porto, Portugal
- Gastroenterology Department, St James University Hospital, Leeds, UK
- Humanitas Clinical and Research Center – IRCCS -, Rozzano [Mi], Italy, and Humanitas University, Department of Biomedical Sciences Milan, Italy
- Hospital Universitari Mutua Terrassa, Digestive Diseases Department, Terrassa, Catalonia, and Centro de Investigación Biomedica en red de Enfermedades Hepaticas y Digestivas CIBERehd, Madrid, Spain
- Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA
- Department of Gastroenterology, Barts Health NHS Trust, Royal London Hospital, London, UK
- Department of Gastroenterology, Venizeleio General Hospital, Heraklion, Greece
- Department of Gastroenterology, Sheba Medical Center, Ramat Gan, Israel, and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
- Sorbonne Universite, INSERM, Institut Pierre Louis d’Epidemiologie et de Sante Publique, AP-HP, Hopital Saint- Antoine, Department of Gastroenterology, Paris, France
- Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- Gastroenterology Department, Centro Hospitalar Sao Joao, Porto, Portugal, and Institute of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Portugal
- Outpatient Department of Gastroenterology, Department of Geriatrics, Klinikum Luneburg, University of Hamburg, Luneburg, Germany
- Department of Paediatric Gastroenterology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
- IBD Unit, Department of Gastroenterology, Hospital Clinico San Carlos and Instituto de Investigacion del Hospital Clinico San Carlos [IdISSC], Madrid, Spain
- Ankara University School of Medicine, Department of Gastroenterology, Ankara, Turkey
- Centre Hospitalier de l’Universite de Montreal [CHUM] Pharmacy Department and Faculty of Pharmacy, University de Montreal, Montreal, QC, Canada
- University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland
- Department of Infectious Diseases, Tourcoing Hospital, Tourcoing, France
Countries:
Article Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1093/ecco-jcc/jjab227Additional Notes:
See also: https://doi.org/10.1093/ecco-jcc/jjab225 Journal was previously published by Elsevier until 2015.
Citations (338)
338
Total Citations307
Post-Retraction(90.8%)
30
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
2
Within 30 days
73
Within 1 year
156
After 2+ years
1254
Days since retraction (latest)
Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach
Vlad Ionescu, Gina Gheorghe, Valentin Varlas et al. (5 authors)
Gastroenterology Insights
Open Access
Published: Dec 2022
4 citations
4 citations
337 days after retraction
Pediatric Inflammatory Bowel Disease
Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen
PEDIATRICS
Open Access
Published: Dec 2022
55 citations
55 citations
332 days after retraction
Gut microbiota in the early stage of Crohn’s disease has unique characteristics
Xianzong Ma, Xiaojuan Lu, Wenyu Zhang et al. (14 authors)
Gut Pathogens
Open Access
Published: Dec 2022
34 citations
34 citations
324 days after retraction
A quick guide to diagnosis and treatment of cytomegalovirus infection in the gut: current dilemmas
Iļja Drjagunovs, Sniedze Laivacuma, Indra Zeltiņa et al. (4 authors)
Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences
Open Access
Published: Dec 2022
1 citation
1 citation
311 days after retraction
Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar et al. (7 authors)
Intestinal Research
Open Access
Published: Dec 2022
11 citations
11 citations
311 days after retraction
Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions
Keith M. Sullivan, Francis A. Farraye, Kevin Winthrop et al. (6 authors)
Vaccine
Open Access
Published: Nov 2022
20 citations
20 citations
309 days after retraction
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
R Ferreiro-Iglesias, Alejandro Hernández-Camba, Ruth Serrano Labajos et al. (6 authors)
Gastroenterología y Hepatología (English Edition)
Published: Nov 2022
2 citations
2 citations
306 days after retraction
A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland
Michał Łodyga, Katarzyna Maciejewska, Grażyna Rydzewska
Medical Science Monitor
Open Access
Published: Nov 2022
5 citations
5 citations
304 days after retraction
Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation
A Jentzer, Sébastien Fauteux‐Daniel, Paul O. Verhoeven et al. (12 authors)
Viruses
Open Access
Published: Nov 2022
1 citation
1 citation
302 days after retraction
Severe Acute Colitis: A Countdown Diagnostic Challenge
O. Nacir, Abbas Riyad, Adil Ait Errami et al. (6 authors)
International Journal of Innovative Research in Medical Science
Open Access
Published: Nov 2022
297 days after retraction
Encuesta Sociedad Española de Médicos de Atención Primaria (SEMERGEN) y Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el manejo de pacientes con enfermedad inflamatoria intestinal
Daniel Ginard, Mercedes Ricote, Pilar Nos et al. (8 authors)
Gastroenterología y Hepatología
Open Access
Published: Nov 2022
5 citations
5 citations
297 days after retraction
Recommendations of the Spanish Group on Crohn’s Disease and Ulcerative Colitis on the importance, screening and vaccination in inflammatory bowel disease patients
R Ferreiro-Iglesias, Marta Piqueras, E Ricart et al. (11 authors)
Gastroenterología y Hepatología (English Edition)
Open Access
Published: Nov 2022
2 citations
2 citations
292 days after retraction
Herpes Zoster in Hospitalized Patients With Inflammatory Bowel Disease
Daniela Guerrero Vinsard, Dorothy Wakefield, Raffi Karagozian et al. (4 authors)
Journal of Clinical Gastroenterology
Published: Nov 2022
288 days after retraction
Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis
Wenchang Yang, Kaixiong Tao, Yaxin Wang et al. (11 authors)
Biochemical Pharmacology
Published: Nov 2022
44 citations
44 citations
285 days after retraction
Impact of Epstein–Barr virus infection in patients with inflammatory bowel disease
Hui Zhang, Shuliang Zhao, Zhijun Cao
Frontiers in Immunology
Open Access
Published: Oct 2022
30 citations
30 citations
277 days after retraction
Prophylaxis for <i>Pneumocystis jirovecii</i> pneumonia in patients with inflammatory bowel disease: A systematic review
Caroline M. Sierra, Krishna C. Daiya
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Open Access
Published: Oct 2022
7 citations
7 citations
261 days after retraction
<i>Pneumocystis jirovecii</i> Pneumonia in Patients with Inflammatory Bowel Disease–a Case Series
Sophie Vieujean, Annick Moens, Déborah Hassid et al. (11 authors)
Journal of Crohn s and Colitis
Open Access
Published: Oct 2022
6 citations
6 citations
261 days after retraction
Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agents
Hisashi Shiga, Takahiro Takahashi, Manabu Shiraki et al. (30 authors)
Scandinavian Journal of Gastroenterology
Published: Oct 2022
1 citation
1 citation
261 days after retraction
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early <scp>COVID</scp>‐19 pandemic: the <scp>PREPARE‐IBD</scp> multicentre cohort study
Aamir Saifuddin, Alexandra Kent, Shameer Mehta et al. (15 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Oct 2022
6 citations
6 citations
254 days after retraction
Filgotinib for moderately to severely active ulcerative colitis
Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi et al. (5 authors)
Expert Review of Gastroenterology & Hepatology
Published: Oct 2022
6 citations
6 citations
252 days after retraction
Periodontitis prevalence and severity in inflammatory bowel disease: A case–control study
Giacomo Baima, Mamdouh Muwalla, Giulia Testa et al. (11 authors)
Journal of Periodontology
Open Access
Published: Sep 2022
31 citations
31 citations
235 days after retraction
Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?
Su Hyun Park, Sang Hyoung Park
Gut and Liver
Open Access
Published: Sep 2022
1 citation
1 citation
234 days after retraction
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
Sara Massironi, Lorena Pirola, Giacomo Mulinacci et al. (9 authors)
Inflammatory Bowel Diseases
Published: Aug 2022
2 citations
2 citations
218 days after retraction
Viral Hepatitis in Patients with Inflammatory Bowel Disease
Seung Hwan Shin, Sang Hyoung Park
Korean Journal of Gastroenterology
Open Access
Published: Aug 2022
1 citation
1 citation
213 days after retraction
Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease
Jun Lee
Korean Journal of Gastroenterology
Open Access
Published: Aug 2022
2 citations
2 citations
213 days after retraction
Latent and Active Tuberculosis Infection in Patients with Inflammatory Bowel Disease
Byung Chul Jin, Hee Jin Moon, Sang Wook Kim
Korean Journal of Gastroenterology
Open Access
Published: Aug 2022
3 citations
3 citations
213 days after retraction
Impact of a Structured Report Template on the Quality of Multislice Spiral Computed Tomography Scan Reports for Small Bowel Diseases: A Preliminary Study
Jinghao Chen, Jie Zhou, Shenchu Gong et al. (7 authors)
Iranian Journal of Radiology
Open Access
Published: Aug 2022
204 days after retraction
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19
Raffaele Pellegrino, Gianluca Pellino, Francesco Selvaggi et al. (6 authors)
Digestive and Liver Disease
Open Access
Published: Aug 2022
21 citations
21 citations
201 days after retraction
Vaccination strategies for Korean patients with inflammatory bowel disease
Yoo Jin Lee, Eun Soo Kim
The Korean Journal of Internal Medicine
Open Access
Published: Aug 2022
5 citations
5 citations
196 days after retraction
Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease
Ashkan Rezazadeh Ardabili, Steven Jeuring, Zlatan Mujagic et al. (8 authors)
Alimentary Pharmacology & Therapeutics
Open Access
Published: Jul 2022
23 citations
23 citations
163 days after retraction
<i>Clostridium difficile</i> Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
Edward V. Loftus, Daniel C. Baumgart, K Gecse et al. (10 authors)
Inflammatory Bowel Diseases
Open Access
Published: Jul 2022
3 citations
3 citations
163 days after retraction
Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
Sabino Riestra, Carlos Taxonera, Yamile Zabana et al. (40 authors)
Journal of Clinical Medicine
Open Access
Published: Jul 2022
3 citations
3 citations
162 days after retraction
Evidence-Based Commentary: Testing and Treating Latent Tuberculosis Before Starting Biologics and Small Molecules in Patients with Inflammatory Bowel Disease
Rinkalben Kakadiya, Vishal Sharma
JOURNAL OF GASTROINTESTINAL INFECTIONS
Open Access
Published: Jul 2022
2 citations
2 citations
158 days after retraction
Cytomegalovirus Infection in Ulcerative Colitis: An Ambispective Study from a Single Center
Sumit Bhatia, Anuraag Jena, Ranjini Kudva et al. (4 authors)
JOURNAL OF GASTROINTESTINAL INFECTIONS
Open Access
Published: Jul 2022
158 days after retraction
The diagnosis and management of CMV colitis in IBD patients shows high practice variation: a national survey among gastroenterologists
Rogier Goetgebuer, C. Janneke van der Woude, L Bakker et al. (6 authors)
Scandinavian Journal of Gastroenterology
Open Access
Published: Jun 2022
10 citations
10 citations
157 days after retraction
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study
Aurélien Amiot, Jean‐François Rahier, Filip Baert et al. (100 authors)
Journal of Crohn s and Colitis
Open Access
Published: Jun 2022
13 citations
13 citations
156 days after retraction
Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study
Haydar Celasin, Murat Törüner, Sevda Aghayeva et al. (10 authors)
The Turkish Journal of Gastroenterology
Open Access
Published: Jun 2022
148 days after retraction
The Impact of Inflammatory Bowel Diseases and Related Medications on COVID-19 Severity and Outcome: A Tertiary Referral Center Experience from Turkey
Ramazan Erdem Er, Serkan Duman, Emin Bodakçı et al. (6 authors)
The Turkish Journal of Gastroenterology
Open Access
Published: Jun 2022
1 citation
1 citation
144 days after retraction
Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
Jan Marsal, Manuel Barreiro‐de Acosta, Irina Blumenstein et al. (6 authors)
Frontiers in Medicine
Open Access
Published: Jun 2022
57 citations
57 citations
142 days after retraction
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
Maria Napolitano, Ferdinando D’Amico, Elisa Maria Ragaini et al. (5 authors)
Drug Design Development and Therapy
Open Access
Published: Jun 2022
23 citations
23 citations
128 days after retraction
Stellungnahme der DGVS zur Nutzenbewertung des GBA zum Wirkstoff Filgotinib (Anwendungsgebiet: Colitis Ulcerosa, vorbehandelte Patient*innen)
Unknown Authors
Zeitschrift für Gastroenterologie
Published: Jun 2022
128 days after retraction
Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study
Hong Yang, Zhihua Ran, Meng Jin et al. (4 authors)
Gut and Liver
Open Access
Published: May 2022
7 citations
7 citations
121 days after retraction
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre la importancia, el cribado y la vacunación en pacientes con enfermedad inflamatoria intestinal
R Ferreiro-Iglesias, Marta Piqueras, E Ricart et al. (11 authors)
Gastroenterología y Hepatología
Open Access
Published: May 2022
17 citations
17 citations
110 days after retraction
Immune-mediated disease units: A step forward for patients with inflammatory bowel disease
Esther Chamorro-de-Vega, Luís Menchén
Journal of IMIDs
Open Access
Published: May 2022
108 days after retraction
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
Aleksandra Kubas, Ewa Małecka‐Panas
Journal of Clinical Medicine
Open Access
Published: May 2022
13 citations
13 citations
105 days after retraction
Short interruptions of TNF-inhibitor treatment can be associated with treatment failure in patients with immune-mediated diseases
Tea Lamberg, Taina Sipponen, Sanna Valtanen et al. (25 authors)
Autoimmunity
Open Access
Published: Apr 2022
5 citations
5 citations
94 days after retraction
Health Care Maintenance in Patients with Crohn's Disease
Jana G. Hashash, Francis A. Farraye
Gastroenterology Clinics of North America
Published: Apr 2022
1 citation
1 citation
93 days after retraction
CMV Colitis Mimicking Crohn’s Disease in a Patient with CLL: A Case Report
Eddy Fares, Mayssaa Hoteit, Saliba R. Wehbe et al. (4 authors)
International Journal of Clinical Research
Open Access
Published: Apr 2022
92 days after retraction
Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease
Joshua Kwon, Nader Daoud, Jana G. Hashash et al. (5 authors)
Inflammatory Bowel Diseases
Published: Apr 2022
8 citations
8 citations
91 days after retraction
An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Francesca Ferretti, Rosanna Cannatelli, Maria Camilla Monico et al. (5 authors)
Journal of Clinical Medicine
Open Access
Published: Apr 2022
78 citations
78 citations
86 days after retraction
Quick Stats
Total Citations:
338
Years Since Retraction:
3.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025